|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 54.78 USD | -8.24% |
|
55.52 | +1.35% |
| 07-21 | Barclays Initiates Forte Biosciences at Overweight With $74 Price Target | MT |
| 07-09 | Forte Biosciences, Inc. - Special Call |
Chart calendar Forte Biosciences, Inc.
Upcoming events on Forte Biosciences, Inc.
No events available
Past events on Forte Biosciences, Inc.
| 2026-07-09 | Information meeting | 08:30 |
| 2026-05-29 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-05-29 | Annual General Meeting | 09:00 |
| 2026-05-28 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -36,6 -38,2 4.19% | -70,7 -66,3 -6.62% | -97,4 | -131 | -157 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -35,5 -37,2 4.51% | -68,3 -64,7 -5.69% | -95,4 | -130 | -156 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -35,5 -37,2 4.51% | -69,4 -64,7 -7.3% | -95,5 | -130 | -156 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -12,2 -6,73 -80.83% | -4,71 -4,31 -9.22% | -4,11 | -4,25 | -4,37 |
| Announcement Date | 18/03/24 | 28/03/25 | 31/03/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,63 -13,1 34.07% | -7,35 -8,95 17.87% | -16,1 -7,63 -111.41% | -11,6 -13,4 13.55% | -18,4 -12,5 -47.37% | -24,6 -18,9 -29.74% | -22,4 -20,6 -8.75% | -24,2 | -25,1 | -25,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,16 -8,83 18.98% | -17,7 -12,3 -43.76% | -23,8 -18,4 -29.13% | -21,8 -18,2 -19.37% | -23,6 | -24,6 | -25,2 | |||
|
Net income Million USD | Released Forecast Spread | -7,16 -8,83 18.98% | -11,2 -10,0 -12.49% | -17,7 -12,3 -43.76% | -24,8 -18,4 -34.77% | -22,1 -18,2 -21.42% | -23,6 | -24,6 | -25,2 | ||
|
EPS USD | Released Forecast Spread | -1,76 | -1,37 -0,95 -44.21% | -0,96 -1,00 3.68% | -0,99 -1,03 3.57% | -1,45 -1,22 -18.85% | -1,24 -1,19 -4.49% | -1,03 | -1,03 | -1,05 | |
| Announcement Date | 14/11/24 | 28/03/25 | 15/05/25 | 14/08/25 | 14/11/25 | 31/03/26 | 11/05/26 | - | - | - |
| 2026-07-27 |  | Information meeting | 08:00 |
| 2026-07-28 | | Sales and Revenue Release - Q2 2026 | AH |
| 2026-07-29 | | Earnings release - Q2 2026 | |
| 2026-07-29 | | Earnings presentation | 16:30 |
| 2026-07-29 | | Earnings presentation | 08:30 |
| 2026-07-29 | | Earnings release - Q2 2026 | |
| 2026-07-29 | | Extraordinary General Meeting | 20:30 |
| 2026-07-30 | | Earnings presentation | 08:00 |
| 2026-07-30 | | Earnings release - Q2 2026 | |
| 2026-07-30 | | Extraordinary General Meeting | 02:30 |
Past sector events for Forte Biosciences, Inc.
| 2026-07-24 | | Information meeting | 09:00 |
| 2026-07-23 | | Earnings presentation | 08:30 |
| 2026-07-23 | | Earnings release - Q2 2026 | |
| 2026-07-23 | | Earnings release - Q2 2026 | |
| 2026-07-23 | | Earnings presentation | 16:30 |
| 2026-07-23 | | Earnings release - Q2 2026 | |
| 2026-07-16 | | Information meeting | 08:00 |
| 2026-07-15 | | Extraordinary General Meeting | 20:01 |
| 2026-07-14 | | Information meeting | 17:30 |
| 2026-07-14 | | Présentation aux Actionnaires / Analystes | 00:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- FBRX Stock
- Calendar Forte Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
